Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression.

Gnirss K, Kühl A, Karsten C, Glowacka I, Bertram S, Kaup F, Hofmann H, Pöhlmann S.

Virology. 2012 Mar 1;424(1):3-10. doi: 10.1016/j.virol.2011.11.031. Epub 2012 Jan 4.

2.

Cathepsin B & L are not required for ebola virus replication.

Marzi A, Reinheckel T, Feldmann H.

PLoS Negl Trop Dis. 2012;6(12):e1923. doi: 10.1371/journal.pntd.0001923. Epub 2012 Dec 6.

3.

Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences.

Misasi J, Chandran K, Yang JY, Considine B, Filone CM, Côté M, Sullivan N, Fabozzi G, Hensley L, Cunningham J.

J Virol. 2012 Mar;86(6):3284-92. doi: 10.1128/JVI.06346-11. Epub 2012 Jan 11.

4.

Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization.

Marzi A, Wegele A, Pöhlmann S.

Virology. 2006 Sep 1;352(2):345-56. Epub 2006 Jun 13.

5.

[Ebola and Marburg viruses: the humans strike back].

Alazard-Dany N, Ottmann Terrangle M, Volchkov V.

Med Sci (Paris). 2006 Apr;22(4):405-10. Review. French.

6.

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.

Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L.

J Virol. 2015 Oct;89(19):9932-8. doi: 10.1128/JVI.01337-15. Epub 2015 Jul 22.

7.

Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR.

Marzi A, Möller P, Hanna SL, Harrer T, Eisemann J, Steinkasserer A, Becker S, Baribaud F, Pöhlmann S.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S237-46.

PMID:
17940955
8.

Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.

Usami K, Matsuno K, Igarashi M, Denda-Nagai K, Takada A, Irimura T.

Biochem Biophys Res Commun. 2011 Apr 1;407(1):74-8. doi: 10.1016/j.bbrc.2011.02.110. Epub 2011 Mar 6.

PMID:
21362405
9.

The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.

Feldmann H, Volchkov VE, Volchkova VA, Klenk HD.

Arch Virol Suppl. 1999;15:159-69. Review.

PMID:
10470276
10.

Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger.

Markosyan RM, Miao C, Zheng YM, Melikyan GB, Liu SL, Cohen FS.

PLoS Pathog. 2016 Jan 5;12(1):e1005373. doi: 10.1371/journal.ppat.1005373. eCollection 2016 Jan.

11.

Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway.

Ruedas JB, Arnold CE, Palacios G, Connor JH.

J Virol. 2018 Sep 12;92(19). pii: e00820-18. doi: 10.1128/JVI.00820-18. Print 2018 Oct 1.

PMID:
30021890
12.

The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.

Nelson EA, Dyall J, Hoenen T, Barnes AB, Zhou H, Liang JY, Michelotti J, Dewey WH, DeWald LE, Bennett RS, Morris PJ, Guha R, Klumpp-Thomas C, McKnight C, Chen YC, Xu X, Wang A, Hughes E, Martin S, Thomas C, Jahrling PB, Hensley LE, Olinger GG Jr, White JM.

PLoS Negl Trop Dis. 2017 Apr 12;11(4):e0005540. doi: 10.1371/journal.pntd.0005540. eCollection 2017 Apr.

13.

Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses.

Chan SY, Speck RF, Ma MC, Goldsmith MA.

J Virol. 2000 May;74(10):4933-7.

14.

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM.

Science. 2005 Jun 10;308(5728):1643-5. Epub 2005 Apr 14.

15.

Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.

Radoshitzky SR, Warfield KL, Chi X, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH.

J Virol. 2011 Sep;85(17):8502-13. doi: 10.1128/JVI.02600-10. Epub 2011 Jun 22.

16.

Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.

Zhang X, Ao Z, Bello A, Ran X, Liu S, Wigle J, Kobinger G, Yao X.

Antiviral Res. 2016 Mar;127:20-31. doi: 10.1016/j.antiviral.2016.01.001. Epub 2016 Jan 9.

PMID:
26778707
17.

Analysis of Ebola Virus Entry Into Macrophages.

Dahlmann F, Biedenkopf N, Babler A, Jahnen-Dechent W, Karsten CB, Gnirß K, Schneider H, Wrensch F, O'Callaghan CA, Bertram S, Herrler G, Becker S, Pöhlmann S, Hofmann-Winkler H.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S247-57. doi: 10.1093/infdis/jiv140. Epub 2015 Apr 14.

18.

Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.

Martinez O, Johnson J, Manicassamy B, Rong L, Olinger GG, Hensley LE, Basler CF.

Cell Microbiol. 2010 Feb;12(2):148-57. doi: 10.1111/j.1462-5822.2009.01385.x. Epub 2009 Sep 22.

19.

Cell-cell contact promotes Ebola virus GP-mediated infection.

Miao C, Li M, Zheng YM, Cohen FS, Liu SL.

Virology. 2016 Jan 15;488:202-15. doi: 10.1016/j.virol.2015.11.019. Epub 2015 Dec 3.

20.

Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.

Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE.

J Infect Dis. 2011 Nov;204 Suppl 3:S941-6. doi: 10.1093/infdis/jir321.

PMID:
21987773

Supplemental Content

Support Center